Related Experiment Video
Updated: Jul 5, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Neutrophil-to-albumin ratio predicts 30-day mortality in acute aortic dissection: a retrospective cohort study
Yunxian Chen1, Cheng Ling1, Yang Song1
1Department of Cardiology, Yue Bei People's Hospital, Shantou University Medical College, Shaoguan, China.
Background:
Acute aortic dissection (AAD) carries high early mortality, necessitating reliable prognostic tools. The neutrophil-to-albumin ratio (NPAR) synergistically encapsulates inflammatory activity and nutritional status, yet its prognostic utility in AAD remains underexplored.
Methods:
We retrospectively enrolled 415 patients with AAD diagnosed at Yuebei People's Hospital between January 2020 and December 2024. NPAR was calculated from admission laboratory values and analyzed as both a continuous and categorical variable (tertiles). Logistic regression models were used to assess the association between NPAR and 30-day mortality. Restricted cubic spline (RCS) analysis examined the dose-response relationship. Receiver operating characteristic analysis compared NPAR with NLR, SII, and PLR. Prespecified subgroup analyses examined effect consistency.
Results:
Higher NPAR values were independently associated with increased 30-day mortality (adjusted OR: 1.48; 95% CI: 1.05-2.09; P = 0.027). Patients in the highest NPAR tertile (≥22.37) had significantly greater mortality risk than those in the lowest tertile (<19.95) (adjusted OR: 20.28; 95% CI: 1.45-283.0; P = 0.025). RCS analysis revealed a linear positive association between NPAR and mortality. NPAR demonstrated superior discrimination for 30-day mortality (AUC: 0.741) compared with NLR, SII, and PLR. Subgroup analyses yielded consistent associations across prespecified strata with no significant interactions.
Conclusions:
Elevated admission NPAR is an independent predictor of short-term mortality in AAD. As an easily available and inexpensive biomarker, NPAR may improve early risk stratification and guide clinical decision-making in this high-risk population.